Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Key claim: The Paris Prospective Study III-2 will reassess vascular aging and baroreflex sensitivity 12–16 years apart, identify their determinants, and quantify subsequent cardiovascular disease risk.
Abstract
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Why this matters
The Paris Prospective Study III-2 will reassess vascular aging and baroreflex sensitivity 12–16 years apart, identify their determinants, and quantify subsequent cardiovascular disease risk.